Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Vertigo Treatment Market Research Report Information By Type (BPPV, Labyrinthitis, Vestibular Neuronitis, Meniere’s disease), By Treatment (Anticholinergics, Antihistamines, Benzodiazepines, Others) and By End-User (Hospital, Clinics)-Forecast to 2032


ID: MRFR/HC/6986-HCR | 100 Pages | Author: Kinjoll Dey| May 2024

Vertigo Treatment Market Overview


The vertigo treatment market is anticipated to reach USD 2.36 Billion by 2032 at 4.8% CAGR during the forecast period 2023-2032. Vertigo is a sense of spinning dizziness that can be caused by problems in the brain or inner ear, including sudden head movements, or inflammation in the inner ear due to a viral or bacterial infection. Vertigo can be treated with medications such as steroids that can reduce internal ear inflammation, and water pills that can reduce fluid buildup in the ear.


The increasing initiatives by public and private companies influence the market growth positively. The ever-increasing number of clearances and product launches by key players in the market are likely to act as a promising factor for the vertigo teatment market growth in the near future.


Vertigo Treatment Market Drivers



  • Increase in prevalence of vertigo cases

    • Cases of vertigo are on the rise, with over 20% 50% of the global population affected by vertigo and According to the National Center for Biotechnology Information, in the US, around 26 million people required a visit to an emergency department for dizziness/vertigo.



  • Rapid technological advancements

  • Rise in healthcare expenditure

  • Increasing geriatric population

  • Increasing mergers & acquisitions by prominent market players in the vertigo treatment

  • Growing initiatives to create awareness

    • For instance, the German Center for Vertigo and Balance Disorders (DSGZ) started an initiative called DIZZYNET. The main aim is to create a platform for collaboration and exchange among scientists, physicians, and physiotherapists to understand the treatment options and epidemiology of vertigo. Such initiates help to create awareness regarding symptoms and treatment for vertigo.




Vertigo Treatment Market Restraints



  • Lack of information about the symptoms and causes of vertigo


Vertigo Treatment Market Segmentation


Vertigo Treatment Type Insights




  • Benign Paroxysmal Positional Vertigo (BPPV): Expected to hold the largest share, as benign paroxysmal positional vertigo is the most common form of peripheral vertigo. This type tends to cause short, frequent bouts of vertigo.




  • Labyrinthitis: An inner ear infection causes labyrinthitis form of vertigo. This form of vertigo is usually overlooked as they appear with other symptoms such as fever and earache.




  • Vestibular Neuronitis: Vestibular neuritis is a disorder that affects the nerve of the inner ear. This type of vertigo has a sudden onset and may cause unsteadiness, earache, nausea, and vomiting.




  • Meniere’s disease: This type of vertigo is often so severe that it causes nausea and vomiting. Meniere’s disease also causes hearing loss, ringing in your ears, and a feeling of fullness in your ears.




Vertigo Treatment Treatment Insights




  • Anticholinergics: Anticholinergics are vestibular suppressants and are most important in treating vertigo since anticholinergic drugs that do not cross the blood-brain barrier are ineffective in controlling motion sickness. The most effective single anticholinergic drug for the prophylaxis and treatment of motion sickness is scopolamine. All anticholinergics conventionally used in the management of vertigo or motion sickness have prominent side-effects, often including dry mouth, dilated pupils, and sedation. Anticholinergics are ineffective if administered after symptoms have already appeared.




  • Antihistamines: Centrally acting antihistamines prevent motion sickness and reduce the severity of symptoms, even if taken after the onset of the symptoms. All the antihistamines in general use for control of vertigo also have anticholinergic activity.




  • Benzodiazepines: Benzodiazepines are extremely useful for the management of acute vertigo. They are also helpful in controlling motion sickness and can also minimize anxiety and panic associated with vertigo. Diazepam, clonazepam, lorazepam, and alprazolam are commonly prescribed benzodiazepines for their effect as anxiolytics and antidepressants.




  • Others: The other segment includes antibiotics and other drugs that can help ease the symptoms of vertigo.




Vertigo Treatment End-User Insights




  • Hospital: Hospitals dominate the global market for vertigo treatment. The positive growth of hospitals is attributed to their rising need to offer treatments for various health disorders. Additionally, the large number of hospitals is also driving the growth for the hospital's segment.




  • Clinics: Clinics take up the second-largest share due to the rising number of clinics and the increasing patient population.




Vertigo Treatment Market By Region




  • Americas:It is the largest regional vertigo treatment market owing to the large patient population, rise in prevalence of vertigo, and surge in awareness about the causes of vertigo and its treatments. According to the American Speech-Language-Hearing Association, around 40% of the population in the US experience some form of dizziness or balance difficulty over the course of a lifetime.




  • Europe:The growing presence of the developed pharmaceutical industry and the significant demand for vertigo related therapeutics is driving the market growth of the vertigo treatment in Europe. According to the National Center for Biotechnology Information, the prevalence of vertigo in Germany was 22.9%.




  • Asia-Pacific:The Asia-Pacific region is anticipated to be the fastest-growing region in the global market of vertigo treatment. This region has witnessed a surge in the number of people afflicted with vertigo and other neurological disorders.




  • Middle East & Africa:The smallest market due to limited healthcare infrastructure and limited exposure to technological advancements.




Vertigo Treatment Market Key Players



  • Hoffmann-La Roche (Switzerland)

  • GlaxoSmithKline (UK)

  • Novartis (Switzerland)

  • Pfizer (US)

  • Teva Pharmaceutical (Israel)

  • Sanofi (France)

  • AstraZeneca (UK)

  • Intas Pharmaceutical Ltd (India)

  • Sun Pharmaceutical Industries Ltd (India)

Frequently Asked Questions (FAQ) :

vertigo treatment market is projected grow at approximately 4.80% CAGR during the assessment period (2023-2032).

The valuation of the global vertigo treatment market had reached 1,800 MN in 2018.

By type, the benign paroxysmal positional vertigo (BPPV) segment, by treatment, the anticholinergics segment, and end user, the hospital segment holds the majority shares in the global vertigo treatment market.

North America holds the largest share in the global vertigo treatment market, followed by Europe and the Asia Pacific, respectively.

GlaxoSmithKline (UK), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), Teva Pharmaceutical (Israel), Pfizer (US), Sanofi (France), Intas Pharmaceutical Ltd (India), AstraZeneca (UK), and Sun Pharmaceutical Industries Ltd (India), are some of the major players operating in the global vertigo treatment market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.